# Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429

> **NCT01117233** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04427429
- **DRUG:** PF-04427429
- **DRUG:** PF-04427429
- **DRUG:** PF-04427429
- **DRUG:** PF-04427429

## Key facts

- **NCT ID:** NCT01117233
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117233, "Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01117233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*